S2N Health provides cutting-edge strategy consulting services and SaaS solutions to medical technology companies to maximize the impact and success of their innovations. Since 2011, S2N Health has worked with more than 160 companies, from start-ups to large global organizations, bringing critical insights and analytics to key product, commercial and business decisions. S2N supports clients at all stages, including development, market entry, sales acceleration, and strategic partnering. In 2022, S2N introduced RepSignal, an AI-driven SaaS solution delivering on-demand customer insights and intelligence to med tech commercial teams for successfully targeting and engaging clinical customers.